Stock·NASDAQ·Consumer Defensive
Celsius Holdings Inc. (CELH)
- Market cap
- $7.13B
- P/E
- 122.43
- Dividend yield
- 0.00%
- Street target
- $41.00median of 24 analysts
- 52-week range
- $23.56 $66.00
The short version
Where CELH stands today, in four lines, and what CleaRank Financial AI makes of it.
CELH at a glance
Celsius Holdings Inc. (CELH): Hold, 42/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($29.27 and $35.61).
- Earnings CELH beat estimates in 5 of its last 7 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $79.8M and bought $3.2M over the last 18 months.
- Valuation P/E of 122.4 against 24.2 for the Consumer Defensive sector: a premium to peers (+406%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates Celsius Holdings Inc. (CELH) Hold, with a model score of 42/100.
The analysts' outlook lifts the score most: 18 of 24 analysts rate it a buy and the median target is 45.4% above the price. The trend holds it back most: the price is 20.85% below its 200-day average and 3.68% below its 50-day average, and the 50-day average is 17.82% below the 200-day. The 50-day average stands at $29.27 and the 200-day at $35.61. Over the past year the price fell 56.15%.
Only on CleaRank
Figures we compute ourselves from CELH's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $28.19 is 3.7% below the 50-day simple moving average of $29.27.Price above its 200-day average ›
The price is 20.8% below the 200-day simple moving average of $35.61.50-day average above the 200-day ›
The 50-day average ($29.27) is 17.8% below the 200-day average ($35.61), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 11% of its 52-week range, between $23.56 and $66.00.
CELH share price
Pick a period: each tab shows how far CELH has moved over it, to the last close.
Today's trading
Where CELH sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/4P/E below the sector median ›
The trailing P/E of 122.43 is 405.9% above the Consumer Defensive median of 24.2.P/S below the sector median ›
The price-to-sales ratio of 2.34 is 6.3% above the sector median of 2.2.Profitable over the last 12 months ›
Net income over the last 12 months was $65.3M on revenue of $3.0B, a net margin of 2.1%.Beat estimates in most recent reports ›
CELH beat the EPS estimate in 5 of its last 7 reports.
Key statistics
The headline figures for CELH.
As of October 17, 2026, CELH trades at $28.19, with a market value of $7.13B and a P/E ratio of 122.43.
What the numbers say
CleaRank Financial AI's reading of CELH's valuation, growth and risks.
CELH's trailing P/E of 122.43 compares with a Consumer Defensive median of 24.2, 405.9% above it, which the peer comparison on this page rates as a premium to peers. The price-to-sales ratio of 2.34 sits 6.4% above the sector median of 2.2. For scale, CELH carries a market capitalisation of $7.1B.
Growth outpaces the sector: revenue grew 10.60% in the latest year, against a sector median of 5.3%. Profitability shows a net margin of 4.24% and an operating margin of 19.09%, with a return on equity of 5.11%, below the sector median of 19.7%. Rounding out the fundamentals, CELH reports debt-to-equity of 0.23.
CELH reported its latest quarter on August 6, 2026, and EPS came in at $0.36 a share, which missed the $0.42 estimate by 14.29%. Even so, the share price climbed 16.83% in the following session.
Across its recent reports, CELH has beaten the EPS estimate in 5 of the last 7, yet a beat has not reliably lifted the shares: the stock fell the next session after 3 of those 5 beats. The November 6, 2025 report is the clearest example, a beat of 50.00% that was followed by a 7.86% decline in the stock. Looking ahead, analysts expect this fiscal year's EPS to average $1.43, a rise of 6.7%, and $1.73 next year, a rise of 20.8%.
Normal swings for CELH run at about 2.66% a day. The P/E of 122.43, 405.9% above the sector median, puts CELH at a premium to peers, so weaker results would meet a higher bar. Until the price regains its moving averages, the trend works against holders. The price is 57.29% below its 52-week high of $66.00.
CELH against the Consumer Defensive sector
How CELH compares with the median Consumer Defensive stock CleaRank tracks.
Price to earnings vs sector: CELH trades at a significant premium to sector peers (+406%), suggesting market expectations for superior growth or market position.
Return vs SPY: Since May 6, 2025, CELH has lost 20.6% against a gain of 36.6% for SPY.
Performance against SPY
CELH and the Consumer Defensive sector fund over the same days.
Revenue and earnings
How much CELH sells, and how much of it becomes profit.
Revenue growth: Revenue grew 85.5% in FY2025 to $2.5B, from $1.4B a year earlier.
Profit margin: The net margin was 4.3% in FY2025, down from 10.7% the year before.
Profitable: CELH earned $108M in FY2025.
Earnings reality check
Did CELH beat what analysts expected, and how did the stock react?
Earnings record: CELH beat the analyst estimate in 5 of the last 7 quarters.
Market reaction: The stock fell in the first session after 3 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 6, 2026after close | $0.42 | $0.36 | -14.29% | +16.83% | +21.08% |
| Feb 26, 2026after close | $0.19 | $0.26 | +36.84% | -0.94% | -19.27% |
| Nov 6, 2025after close | $0.28 | $0.42 | +50.00% | -7.86% | -2.33% |
| Aug 7, 2025after close | $0.24 | $0.47 | +95.83% | +3.65% | +13.07% |
| May 6, 2025after close | $0.19 | $0.18 | -5.26% | +0.76% | +6.78% |
| Feb 20, 2025after close | $0.10 | $0.14 | +40.00% | +27.77% | +1.80% |
| Aug 6, 2024after close | $0.25 | $0.28 | +12.00% | -3.81% | +5.05% |
As of October 17, 2026, CELH has beaten the analyst EPS estimate in 5 of its last 7 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on August 6, 2026, came in 14.29% below the estimate and the stock moved +16.83% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 49.8, in neutral territory.RSI above 50 ›
An RSI of 49.8 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of CELH
The score, the reasoning behind it, and what could move the price next.
CELH is in a downtrend. At $28.19, the stock sits 3.68% below its 50-day average of $29.27 and 20.85% below its 200-day average of $35.61. It is also near the bottom of its 52-week range: the price is 19.65% above the low of $23.56, and 57.29% below the high of $66.00. A 50-day average 17.82% below the 200-day average points the same way as the price, so the weakness is confirmed rather than contradicted.
The record is negative across every period shown: the price fell 2.76% over the past three months, fell 20.03% over the past six months and fell 56.15% over the past year. The 14-day RSI of 49.8 is in the neutral zone, and the MACD line is negative.
Earnings miss ›
The August 6, 2026 report missed the EPS estimate by 14.29%, and the share price rose 16.83% in the first session after it.
Source: Earnings report, August 6, 2026
Analyst downgrade ›
Maxim Group downgraded it to Hold from Buy on August 8, 2026.
Source: Analyst action, Maxim Group, August 8, 2026Analyst downgrade ›
Maxim Group downgraded it to Hold from Buy on August 7, 2026.
Source: Analyst action, Maxim Group, August 7, 2026
- Two levels matter most right now: the 50-day SMA at $29.27 above the price, and the 20-day EMA at $28.03 below it.
- The 14-day RSI is 49.8, which is neutral, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum.
- CELH's share price rose 16.83% in the first session after the August 6, 2026 report, and the company has beaten estimates in 5 of the last 7 reports.
The trend is down because CELH trades beneath both its 50-day ($29.27) and 200-day ($35.61) averages. A move back above the 50-day would be the first sign of repair. That average, at $29.27, is also the nearest level above the price.
The next marker below the price is the 20-day EMA, which sits at $28.03.
Technical indicators
Momentum and trend for CELH, from its daily closes.
As of October 17, 2026, with CELH at $28.19, its 14-day RSI is 49.8 (neutral territory), its 50-day simple moving average is $29.27 and its 200-day is $35.61.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What CELH moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, CELH's 1-year correlation of daily returns is +0.23 with S&P 500 (SPY), +0.21 with Nasdaq 100 (QQQ), +0.15 with Bitcoin (BTC) and +0.11 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
18 of 24 analysts rate it a buy or strong buy, 6 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $41.00 is 45.4% above the price.More buy ratings than three months ago ›
18 of 24 rate it a buy now, against 20 of 23 three months ago.
CELH Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Aug 10, 2026 | Stephens & Co. | Maintains | Overweight |
| Aug 8, 2026 | Maxim Group | Downgrade | Hold |
| Aug 7, 2026 | Maxim Group | Downgrade | Hold |
| Aug 7, 2026 | UBS | Maintains | Buy |
| Aug 7, 2026 | Citigroup | Maintains | Buy |
| Aug 7, 2026 | Morgan Stanley | Maintains | Overweight |
As of October 17, 2026, 24 Wall Street analysts cover CELH: 18 rate it a buy or strong buy, 6 a hold and 0 a sell or strong sell. Their 12-month price targets range from $26.00 to $64.00, with a median of $41.00, 45.4% above the price of $28.19.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
CELH trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from CELH's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much CELH tends to move, against the market and on its own.
The long record
CELH's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 2.66% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 77.8%, from May 2024 to February 2025; the price is still 70.6% below that peak.Most 1-year holds ended higher ›
64% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $397,042, against $42,055 in the S&P 500 (SPY).
CELH Drawdowns & Recovery
As of October 17, 2026, CELH's worst peak-to-trough fall over the last 10 years with dividends reinvested was -77.8% (May 2024 to February 2025); it is still 70.6% below that peak, and 64% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into CELH in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: CELH beat the S&P 500 over this period: $397,042 against $42,055.
A $10,000 investment in CELH in October 2016 would be worth about $397,042 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to CELH, and which have not.
Strongest month, May: an average of +17.48%, up in 9 of 10 years.
Weakest month, September: an average of -3.32%, up in 4 of 10 years.
This month, October: has averaged -0.91%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, CELH's strongest calendar month has been May (average +17.48%, up in 9 of 10 years) and its weakest September (average -3.32%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in CELH, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CELH today could grow to about $30,614 by 2036 in the base case, with a 90th-percentile outcome near $232,260 and a 10th-percentile outcome around $4,035. Projections are statistical simulations, not guarantees.
CELH Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $44.10 for CELH by 2030 in the base case, from $28.19 today (1.6x over 4 years). The 10th-percentile path ends near $12.24. These are outcomes of a Monte Carlo simulation run on CELH's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $16.61 | $31.53 | $59.84 | |
| 2028 | $14.25 | $35.26 | $87.27 | |
| 2029 | $13.00 | $39.43 | $120 | |
| 2030 | $12.24 | $44.10 | $159 | |
| 2031 | $11.77 | $49.32 | $207 |
Method: a lognormal simulation of CELH's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. CELH is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation.
Insider trading
What the people running the company have bought and sold.
CELH insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $3.2M on the open market and sold $79.8M.
As of October 17, 2026, CELH insiders reported 16 open-market sales worth $79.8M and 8 open-market purchases worth $3.2M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Damon Desantis
Director
|
Buy | 36.0K | $1.0M |
| Sep 15, 2026 | Hal Kravitz
Director
|
Buy | 12.0K | $336.0K |
| Sep 10, 2026 | John Erick Fieldly
Chief Executive Officer
|
Buy | 18.0K | $493.8K |
| Aug 7, 2026 | Fletcher F Previn
Director
|
Grant | 3.8K | $105.9K |
| May 22, 2026 | John Erick Fieldly
Chief Executive Officer
|
Buy | 8.5K | $248.8K |
| May 22, 2026 | Hal Kravitz
Director
|
Buy | 8.4K | $249.7K |
| May 21, 2026 | Eric Hanson
President
|
Buy | 7.5K | $217.8K |
| Mar 2, 2026 | Joyce Russell
Director
|
Sell | 2.9K | $147.8K |
| Mar 2, 2026 | Thi Tuyet Trinh Lam
Officer
|
Grant | 9.2K | - |
| Feb 27, 2026 | Nicholas Castaldo
Director
|
Grant | 2.6K | - |
| Feb 27, 2026 | Damon Desantis
Director
|
Grant | 2.6K | - |
| Feb 27, 2026 | John Erick Fieldly
Chief Executive Officer
|
Grant | 42.0K | - |
| Feb 27, 2026 | Eric Hanson
President
|
Grant | 10.7K | - |
| Feb 27, 2026 | Hal Kravitz
Director
|
Grant | 2.6K | - |
| Feb 27, 2026 | Jarrod Langhans
Chief Financial Officer
|
Grant | 15.0K | - |
| Feb 27, 2026 | Caroline S Levy
Director
|
Grant | 2.6K | - |
| Feb 27, 2026 | Richard Stephen Mattessich
Officer
|
Grant | 8.8K | - |
| Feb 27, 2026 | Hans Mj Melotte
Director
|
Grant | 2.6K | - |
| Feb 27, 2026 | Cheryl S Miller
Director
|
Grant | 2.6K | - |
| Feb 27, 2026 | Joyce Russell
Director
|
Grant | 2.6K | - |
| Feb 27, 2026 | Paul H Storey
Officer
|
Grant | 8.8K | - |
| Dec 9, 2025 | John Erick Fieldly
Chief Executive Officer
|
Grant | 18.6K | - |
| Dec 9, 2025 | Tony Guilfoyle
Officer
|
Grant | 11.1K | - |
| Dec 9, 2025 | Eric Hanson
President
|
Grant | 11.1K | - |
| Dec 9, 2025 | Jarrod Langhans
Chief Financial Officer
|
Grant | 11.1K | - |
| Dec 9, 2025 | Richard Stephen Mattessich
Officer
|
Grant | 11.1K | - |
| Dec 9, 2025 | Paul H Storey
Officer
|
Grant | 11.1K | - |
| Nov 13, 2025 | Hal Kravitz
Director
|
Buy | 10.0K | $452.4K |
| Nov 12, 2025 | Eric Hanson
President
|
Buy | 4.6K | $200.2K |
| Oct 16, 2025 | Jarrod Langhans
Chief Financial Officer
|
Sell | 5.0K | $325.0K |
| Oct 10, 2025 | William H Milmoe
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 40.0K | $2.5M |
| Sep 3, 2025 | Paul H Storey
Officer
|
Sell | 7.5K | $457.0K |
| Aug 18, 2025 | Jarrod Langhans
Chief Financial Officer
|
Sell | 5.0K | $300.0K |
| Aug 7, 2025 | John Erick Fieldly
Chief Executive Officer
|
Sell | 143.2K | $7.3M |
| Aug 7, 2025 | Jarrod Langhans
Chief Financial Officer
|
Sell | 5.0K | $255.9K |
| Jul 31, 2025 | Dean Desantis
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 100.0K | $4.8M |
| Jul 31, 2025 | Deborah Desantis
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 100.0K | $4.8M |
| Jul 31, 2025 | William H Milmoe
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 100.0K | $4.8M |
| Jul 29, 2025 | Dean Desantis
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 200.0K | $9.5M |
| Jul 29, 2025 | Deborah Desantis
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 200.0K | $9.5M |
| Jul 29, 2025 | William H Milmoe
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 200.0K | $9.5M |
| Jul 1, 2025 | William H Milmoe
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 300.0K | $14.2M |
| Jun 24, 2025 | John Erick Fieldly
Chief Executive Officer
|
Sell | 130.8K | $5.9M |
| Jun 10, 2025 | John Erick Fieldly
Chief Executive Officer
|
Sell | 132.2K | $5.7M |
| May 30, 2025 | Eric Hanson
President
|
Grant | 46.9K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.